IL147380A0 - Bioconjugate - Google Patents

Bioconjugate

Info

Publication number
IL147380A0
IL147380A0 IL14738000A IL14738000A IL147380A0 IL 147380 A0 IL147380 A0 IL 147380A0 IL 14738000 A IL14738000 A IL 14738000A IL 14738000 A IL14738000 A IL 14738000A IL 147380 A0 IL147380 A0 IL 147380A0
Authority
IL
Israel
Prior art keywords
molecules
polycations
polycation bioconjugates
transport
enhancing
Prior art date
Application number
IL14738000A
Other languages
English (en)
Original Assignee
Szegoe Peter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Szegoe Peter filed Critical Szegoe Peter
Publication of IL147380A0 publication Critical patent/IL147380A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyamides (AREA)
  • Materials For Medical Uses (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL14738000A 1999-06-29 2000-06-28 Bioconjugate IL147380A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9902217A HUP9902217A3 (en) 1999-06-29 1999-06-29 Polycation based bioconjugates and process for producing thereof
PCT/HU2000/000061 WO2001000242A2 (en) 1999-06-29 2000-06-28 Polycation-based bioconjugates

Publications (1)

Publication Number Publication Date
IL147380A0 true IL147380A0 (en) 2002-08-14

Family

ID=89998595

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14738000A IL147380A0 (en) 1999-06-29 2000-06-28 Bioconjugate
IL147380A IL147380A (en) 1999-06-29 2001-12-27 A multi-positive bioconjugate suitable for the transfer of active ingredients within the body

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147380A IL147380A (en) 1999-06-29 2001-12-27 A multi-positive bioconjugate suitable for the transfer of active ingredients within the body

Country Status (23)

Country Link
US (2) US6727347B1 (de)
EP (1) EP1202748B1 (de)
JP (1) JP2003503363A (de)
KR (1) KR100795093B1 (de)
CN (1) CN1371288A (de)
AT (1) ATE408420T1 (de)
AU (1) AU784031B2 (de)
BR (1) BR0012633A (de)
CA (1) CA2377074A1 (de)
CZ (1) CZ20014701A3 (de)
DE (1) DE60040294D1 (de)
EE (1) EE200100715A (de)
HU (1) HUP9902217A3 (de)
IL (2) IL147380A0 (de)
MX (1) MXPA02000450A (de)
NO (1) NO20016391L (de)
NZ (1) NZ516666A (de)
PL (1) PL353933A1 (de)
RU (1) RU2250782C2 (de)
SK (1) SK19222001A3 (de)
UA (1) UA76940C2 (de)
WO (1) WO2001000242A2 (de)
ZA (1) ZA200200266B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9902217A3 (en) * 1999-06-29 2002-07-29 Szegoe Peter Polycation based bioconjugates and process for producing thereof
AU8149901A (en) * 2000-03-21 2001-10-03 Wisconsin Alummi Res Foundatio Methods and reagents for regulation of cellular responses in biological systems
EP1615665A4 (de) * 2003-04-10 2010-10-06 3M Innovative Properties Co Abgabe von die immunantwort modifizierenden verbindungen
RU2270690C1 (ru) * 2004-06-11 2006-02-27 Государственный научный центр вирусологии и биотехнологии "Вектор" (ГНЦ ВБ "Вектор") Комплексное анти-вич соединение
US8168922B2 (en) * 2004-10-18 2012-05-01 Lincoln Global, Inc. Self-shielded flux cored electrode
US7834065B2 (en) * 2005-01-31 2010-11-16 Bmg Incorporated Medical-use two part reactive adhesive and medical-use resin having self-degradation property
JP4989039B2 (ja) * 2005-04-27 2012-08-01 Ｊｎｃ株式会社 核酸複合体及びそれを用いる細胞内への核酸導入方法
TW200800235A (en) * 2005-10-18 2008-01-01 Otsuka Pharma Co Ltd Carrier composition for nucleic acid transport
CN102124098B (zh) 2008-06-27 2014-03-12 博傲沃德株式会社 细胞及组织的冷冻保存用组合物
CN101891889B (zh) * 2010-08-18 2012-05-23 中国科学院长春应用化学研究所 阳离子聚合物及其制备方法
US8541556B1 (en) 2012-03-02 2013-09-24 Empire Technology Development Llc Lignin derivatives and uses thereof
US9095142B2 (en) 2012-06-28 2015-08-04 Empire Technology Development Llc Lignin derivatives having polycations and uses thereof
EP2944195A1 (de) * 2014-05-15 2015-11-18 Monier Tadros Negativ geladene Matrix und Verwendung davon

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701521A (en) 1978-07-17 1987-10-20 The Trustees Of Boston University Method of effecting cellular uptake of molecules
US4847240A (en) 1978-01-16 1989-07-11 The Trustees Of Boston University Method of effecting cellular uptake of molecules
JPS6356501A (ja) * 1986-08-26 1988-03-11 Chisso Corp アフイニテイークロマトグラフイー用カラム充填剤及びその製造方法
HU202553B (en) 1987-10-21 1991-03-28 Mta Kutatas Es Szervezetelemzo Process for producing isopolypeptides composed of diamino monokarboxylic acids and pharmaceutical compositions comprising same, as well as plant protective comprising polyisolysine
JPH0413741A (ja) * 1990-05-02 1992-01-17 Chisso Corp ペクチン・ポリリシン高分子電解質複合体
JPH05246963A (ja) * 1992-03-02 1993-09-24 Kanegafuchi Chem Ind Co Ltd ε−ポリリジン誘導体
DE4331011A1 (de) * 1993-09-13 1995-03-16 Bayer Ag Nukleinsäuren-bindende Oligomere mit C-Verzweigung für Therapie und Diagnostik
EP0915832B1 (de) * 1996-08-05 2002-10-02 Prolinx, Inc. Komplexbildner für boronverbindung und hochstabile komplexe
JP4606524B2 (ja) * 1997-11-19 2011-01-05 チッソ株式会社 ポリリジン、及びポリリジンの製造方法、及びポリリジン組成物、及びエンドトキシンを除去する医薬品の生産方法
HUP9902217A3 (en) * 1999-06-29 2002-07-29 Szegoe Peter Polycation based bioconjugates and process for producing thereof

Also Published As

Publication number Publication date
CZ20014701A3 (cs) 2002-06-12
EE200100715A (et) 2003-02-17
ATE408420T1 (de) 2008-10-15
US7090846B2 (en) 2006-08-15
RU2250782C2 (ru) 2005-04-27
UA76940C2 (en) 2006-10-16
HU9902217D0 (en) 1999-08-30
DE60040294D1 (de) 2008-10-30
US6727347B1 (en) 2004-04-27
NO20016391D0 (no) 2001-12-27
CN1371288A (zh) 2002-09-25
US20040220083A1 (en) 2004-11-04
AU5835100A (en) 2001-01-31
SK19222001A3 (sk) 2004-05-04
HUP9902217A3 (en) 2002-07-29
CA2377074A1 (en) 2001-01-04
MXPA02000450A (es) 2002-07-02
KR100795093B1 (ko) 2008-01-17
WO2001000242A2 (en) 2001-01-04
ZA200200266B (en) 2003-06-25
EP1202748A2 (de) 2002-05-08
JP2003503363A (ja) 2003-01-28
PL353933A1 (en) 2003-12-15
AU784031B2 (en) 2006-01-19
EP1202748B1 (de) 2008-09-17
WO2001000242A3 (en) 2001-11-22
NZ516666A (en) 2004-04-30
KR20020031352A (ko) 2002-05-01
NO20016391L (no) 2002-02-04
IL147380A (en) 2007-02-11
HUP9902217A2 (hu) 2001-04-28
BR0012633A (pt) 2002-04-02

Similar Documents

Publication Publication Date Title
IL147380A0 (en) Bioconjugate
DE69330715D1 (de) Antitumor quinazoline
ATE264685T1 (de) Angesäuertes nitrit zur verwendung als antimikrobielles mittel
WO1999035170A8 (en) Compositions and methods for the treatment of tumor
EP1374908A3 (de) Polymere-Arzneimittel Konjugate die eine Hydrazidolinkergruppe enthalten
WO2001004135A3 (en) Crosslinked dna condensate compositions and gene delivery methods
WO2004080425A3 (en) Polypeptide compounds for inhibiting angiogenesis and tumor growth
WO1999014327A3 (en) Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer
GB9912476D0 (en) Organic compounds
EA200900049A1 (ru) Обработка изделий, в частности содержащих целлюлозу изделий и(или) помещений
AU2290000A (en) Phenanthridine-n-oxides with pde-iv inhibiting activity
DE69940980D1 (de) Rana pipiens proteine und deren verwendung in der behandlung von tumoren
SI1147088T1 (sl) 6-arilfenantridini s PDE-IV inhibirajoco aktivnostjo
WO2000032765A3 (en) Ribozyme therapy for the treatment and/or prevention of restenosis
MXPA02005045A (es) Preparaciones farmaceuticas que contiene agentes citostaticos y aceptores de electrones para el tratamiento de cancer.
AP2000001984A0 (en) Combination of protein farnesyltrandferase and HMG COA reductase inhibitors and their use to treat cancer.
WO2004014319A3 (en) Screening strategy for anticancer drugs
ATE293991T1 (de) VERWENDUNG EINES MIT DEM PEPTID ßELAGIGILTVß ASSOZIIERTEN ENTEROBAKTERIEN-PROTEINS OMPA ZUR BEHANDLUNG VON MELANOMEN
DE60011677D1 (en) Tryptase-inhibitoren
EP1462113A4 (de) ZELLWACHSTUMSHEMMER MIT ANTI-PepT-ANTIKÖRPER
WO2002028874A3 (en) Tumor proliferation inhibitors
MX9707808A (es) Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres.
IL142088A0 (en) Methods and compositions for inhibiting neoplastic cell growth
WO2003026696A1 (fr) Procede permettant de maitriser la proliferation de cellules cancereuses et la mort cellulaire
WO2000015175A3 (en) Use as an active substance of molecules binding to beta-1-integrin with the capacity to kill cells

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed